Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 2,551–2,575 of 7,816 matching trials · page 103 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Assessing the Effectiveness of an Approach for Vocal Behaviors in Older People Living in Nursing Homes NCT03506672 Approach based on the meanings of vocal behaviours; Usual practices Runs in: Canada · 7 sites |
NA other |
COMPLETED | 157 | Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal OTHER |
2025-04-25 |
|
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) NCT03740178 MK-4334; Placebo to MK-4334; Donepepzil |
PHASE1 other |
WITHDRAWN | 0 | Merck Sharp & Dohme LLC INDUSTRY |
2025-04-25 |
|
Functionally-tailored Oral Care Intervention for Community-dwelling Older Adults With Dementia and Their Caregivers NCT04238520 Functionally Tailored Oral Care Intervention; Control Intervention Runs in: United States · 1 site |
NA other |
COMPLETED | 26 | Xi Chen OTHER |
2025-04-25 |
|
Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation NCT06945614 Xenon gas inhalation Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 16 | General Biophysics LLC INDUSTRY |
2025-04-25 |
|
Effects of tDCS on Apraxia of Speech in Non-Fluent Primary Progressive Aphasia NCT04486586 Active tDCS plus Speech-Language Therapy; Sham plus Speech-Language Therapy Runs in: United States · 1 site |
NA other |
WITHDRAWN | 0 | Johns Hopkins University OTHER |
2025-04-24 |
|
Huntington's Disease Biobank: Advancing Remote Monitoring and Deep Phenotyping NCT06941662 computer vision, remote monitoring, blood, urine, wrist bands, mobile-app Runs in: United States · 1 site |
NA other |
RECRUITING | 200 | Stanford University OTHER |
2025-04-24 |
|
Personalized Medicine in the Elderly With Vision Impairment and Mild Cognitive Impairment NCT06942728 nLIFE EyeFitness Runs in: Italy · 1 site |
NA other |
NOT_YET_RECRUITING | 24 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS OTHER |
2025-04-24 |
|
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease NCT05310071 Aducanumab; Placebo Runs in: Australia; Belgium; Brazil; Canada; Finland; France; Germ... · 265 sites |
PHASE3 anti-amyloid-antibody |
TERMINATED | 1,027 | Biogen INDUSTRY |
2025-04-23 |
|
ASURE: Alzheimer Study Using oRal Edaravone NCT05323812 TW001; Placebo Runs in: Croatia; Netherlands · 6 sites |
PHASE2 other |
COMPLETED | 61 | Treeway B.V. INDUSTRY |
2025-04-23 |
|
ScentAware and OCT in MCI vs HC NCT06377241 ScentAware; UPSIT Runs in: United States · 1 site |
NA other |
TERMINATED | 20 | University of Wisconsin, Madison OTHER |
2025-04-23 |
|
Responding to Elder Abuse in GERiAtric Care - Dementia NCT06659822 Runs in: Sweden · 2 sites |
NA other |
COMPLETED | 216 | Region Östergötland OTHER |
2025-04-23 |
|
The REMINDER Program for Older Adults Supported by Residential and Daycare Facilities NCT06733181 REMINDER intervention Runs in: Portugal · 1 site |
NA other |
COMPLETED | 25 | University of Coimbra OTHER |
2025-04-23 |
|
Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients NCT04388254 Simufilam 100 mg oral tablet; Placebo Runs in: Canada; United States · 17 sites |
PHASE2 other |
COMPLETED | 220 | Cassava Sciences, Inc. INDUSTRY |
2025-04-22 |
|
Moving Together: An Online Group Movement Program for People Living With Memory Loss and Caregivers NCT04621448 Moving Together Runs in: United States · 1 site |
NA other |
COMPLETED | 224 | University of California, San Francisco OTHER |
2025-04-22 |
|
Cognitive Stimulation and Strength Training in Older Adults With Cognitive Impairment NCT06666088 Cognitive stimulation and Strength training Runs in: Spain · 1 site |
NA other |
COMPLETED | 81 | University of Jaén OTHER |
2025-04-22 |
|
Investigation of Different Rehabilitation Approaches in Older Adults With Mild Cognitive Impairment NCT06837493 Resistance based hand exercises and functional task-oriented hand e... Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 47 | Uşak University OTHER |
2025-04-22 |
|
Does EVOO Induce Gene and Metabolic Changes in Healthy Subjects NCT05929924 Extra virgin olive oil Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 40 | Augusta University OTHER |
2025-04-20 |
|
Early-phase Telecare Programs for Minor Stroke NCT06306144 Psychoeducation; Computerised Cognitive Stimulation; Usual Care Runs in: France · 3 sites |
NA other |
NOT_YET_RECRUITING | 80 | Hospices Civils de Lyon OTHER |
2025-04-18 |
|
Kimel Family Centre for Brain Health and Wellness NCT06933667 Physical Activity; Brain-healthy Eating; Cognitive Engagement; Soci... Runs in: Canada · 1 site |
NA other |
RECRUITING | 450 | Baycrest OTHER |
2025-04-18 |
|
Imaging Inflammation in Alzheimer's Disease With 11C-ER176 NCT03744312 11C-ER176; Florbetaben Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 9 | Columbia University OTHER |
2025-04-17 |
|
A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age. NCT03752294 Dabigatran; Placebo - Cap |
PHASE1 other |
WITHDRAWN | 0 | University of Rhode Island OTHER |
2025-04-17 |
|
Hearing Aid and Individuals With Cognitive Disorders NCT04049643 Audiologist-based fitting; Service-only Fitting; Device-only fitting Runs in: United States · 2 sites |
NA other |
COMPLETED | 17 | Yu-Hsiang Wu OTHER |
2025-04-17 |
|
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia NCT05374278 [18F]RP-115 PET/MRI or PET/CT and MRI Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 102 | David Wilson OTHER |
2025-04-17 |
|
At Home Gamma tACS in Alzheimer's Disease (tACS@Home) NCT05643326 40 Hz transcranial alternating current stimulation; Sham stimulation Runs in: Italy · 1 site |
NA other |
COMPLETED | 53 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia OTHER |
2025-04-17 |
|
Reminiscence Therapy in Individuals With Dementia NCT06180694 Reminiscence therapy Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 28 | Amasya University OTHER |
2025-04-17 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial